Accession | Title | Series type(s) | Organism(s) | Samples | GDS | Supplementary | Contact | Release date |
---|---|---|---|---|---|---|---|---|
![]() |
![]() |
![]() |
||||||
GSE288087 |
Non-Invasive Detection of Allele-Specific CRISPR-SaCas9-KKH Disruption of TOR1A DYT1 Allele in A Xenograft Mouse Model
|
|
42 | Koen Breyne | Mar 01, 2025 | |||
GSE282436 |
Development of a potent epigenetic editor targeting human PCSK9 with durable reduction of cholesterol in mice and non-human primates [hybrid capture methylseq]
|
|
66 | Frederic Tremblay | Feb 05, 2025 | |||
GSE282522 |
Development of a potent epigenetic editor targeting human PCSK9 with durable reduction of cholesterol in mice and non-human primates
|
|
96 | Frederic Tremblay | Feb 04, 2025 | |||
GSE285667 |
Genome-wide CRISPR guide RNA design and specificity analysis with GuideScan2
|
|
42 | Yuri Pritykin | Jan 08, 2025 | |||
GSE272454 |
Characterization and bioinformatic filtering of ambient gRNAs in single-cell CRISPR screens using CLEANSER [CRISPR]
|
|
6 | Charles Gersbach | Oct 08, 2024 | |||
GSE277075 |
Identification of rejection-associated indirect CD4 T cell epitopes provides a target for donor-specific transplant tolerance
|
|
36 | Christian Larsen | Sep 17, 2024 | |||
GSE119148 |
Chromatin Conformation Dynamics are essential to Control the Transcription of INK4/ARF locus
|
|
16 | Chunliang Li | Aug 01, 2024 | |||
GSE272134 |
In vivo CRISPR base editing for treatment of Huntington’s disease
|
|
145 | Pablo Perez-Pinera | Jul 12, 2024 | |||
GSE202039 |
High-resolution transcriptional analysis of immunoglobulin variable regions reveals the absence of direct relationships between somatic hypermutation, nascent transcription and epigenetic marks [MutPE]
|
|
36 | Maximilian Christian von der Linde | Jun 22, 2024 | |||
GSE202042 |
High-resolution transcriptional analysis of immunoglobulin variable regions reveals the absence of direct relationships between somatic hypermutation, nascent transcription and epigenetic marks
|
|
78 | Maximilian Christian von der Linde | Jun 22, 2024 | |||
GSE256232 |
Quantitative analysis of cis-regulatory elements in transcription with KAS-ATAC-seq
|
|
67 | Ruitu Lyu | Jun 20, 2024 | |||
GSE229212 |
Development of a ß-Globin Gene Replacement Strategy as a Therapeutic Approach for ß-Hemoglobinopathies
|
|
69 | Kristen Seim | Apr 01, 2024 | |||
GSE246586 |
SPLICER: A Highly Efficient Base Editing Toolbox That Enables in vivo Exon Skipping For Targeting Alzheimer’s Disease [miSeq]
|
|
177 | Pablo Pinera | Dec 10, 2023 | |||
GSE246588 |
SPLICER: A Highly Efficient Base Editing Toolbox That Enables in vivo Exon Skipping For Targeting Alzheimer’s Disease
|
|
183 | Pablo Pinera | Dec 10, 2023 | |||
GSE229783 |
Combinatorial genetic strategy accelerates the discovery of cancer genotype-phenotype associations
|
|
36 | John K. Lee | Dec 01, 2023 | |||
GSE206445 |
Base editor induced mutation spectrum in GFP, human ATP1a1, human TP53BP1 and murine MyoD
|
|
134 | Richard Chahwan | Oct 30, 2023 | |||
GSE245630 |
TIME-Seq Enables Scalable and Inexpensive Epigenetic Age Predictions.
|
|
175 | Patrick T Griffin | Oct 19, 2023 | |||
GSE232346 |
TIME-Seq Enables Scalable and Inexpensive Epigenetic Age Predictions
|
|
103 | Patrick T Griffin | Oct 12, 2023 | |||
GSE234803 |
Amino acid availability is a crucial factor for survivability of cancer cells
|
|
20 | Laura Hinze | Sep 13, 2023 | |||
GSE235673 |
Targeting Duchenne Muscular Dystrophy by Skipping DMD Exon 45 with Base Editors
|
|
158 | Michael Gapinske | Jul 20, 2023 |